AFP11h
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...
NOLA.com1d
Get Back in the Game: Managing Knee Pain with ZILRETTA®
For active New Orleanians, knee osteoarthritis (OA) pain can sideline even the most passionate participants. Whether it’s ...
Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™
Zevra to receive a 2025 New Treatment Award for MIPLYFFA™ at the 21st Annual WORLDSymposiumEight abstracts discussing data and clinical ...
Navigating advanced bladder cancer: One caregiver's journey
Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...
A drug got recalled after someone saw ‘black matter’ that can cause stroke or death
“If the particulate matter enters the blood vessels, it can travel to various organs and potentially block blood vessels in ...
manilatimes3d
60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment ...
Le Lézard2d
Mitsubishi Tanabe Pharma America Announces Real-World Data Analysis of Disease Progression with RADICAVA® (edaravone) in ALS
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of a retrospective analysis of real-world data in the Journal of Comparative Effectiveness Research (JCER). The study ...
How One Woman Advocates for Her Vitiligo Care — and for Others with the Condition
It wasn’t until the first time that I saw someone else with vitiligo in person that my perception changed. This stranger didn’t seem to have a care in the world about his spots. He seemed so ...